HeartBeam Inc
BEAT
Get informed when a big investor buys or sells
+ FollowMarket Cap$27.38M
Close$
$0.13
74.2% downside
Current Fair Value
74.2% downsideOvervalued by 74.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $27.38 Million |
|---|---|
| Enterprise Value | $18.66 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.62 |
| Beta | -0.79 |
| Outstanding Shares | 52,774,898 |
Return
| Return on Equity | -248.21% |
|---|---|
| Return on Assets | -190.81% |
| Return on Invested Capital | -250.08% |
Valuation & Multiples
| P/E Ratio | -0.95 |
|---|---|
| PEG | -72.59 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.91 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$147,400
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$108,333
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 12.68%▼ 0.86% |
|---|---|
| Total Invested | $6.28M▼ 42.68% |
| Investors Holding | 38▼ 3.00% |
ESG Score
No data
About BioTelemetry Inc
CEO: Joseph Capper